Brazilian hospital’s early action system prevents medication errors

Around the world / 06 April 2018

At the Hospital Estadual Sumaré, extra safety measures help avoid medication errors, and an ME-prevention method based on the principles of signal detection is being investigated.


The Hospital Estadual Sumaré (HES) is one of the hospitals of the University of Campinas (Unicamp), a public university in the state of São Paulo, Brazil. The hospital was opened in September 2000, and it is an important centre for education and in-service training for students from the School of Medical Sciences. 

HES was the first public hospital in Brazil to be certified with a higher grade in the Brazilian accreditation system for healthcare units, and the first hospital outside of the state capitals to be certified by the healthcare standards organisation Accreditation Canada, again at a higher level. Quality management is an important part of the hospital’s institutional culture. Following a recommendation by the regulatory authority of São Paulo, a pharmacovigilance commission was established in 2003 at the hospital, formed by a physician, a nurse, and a pharmacist. From the beginning, medication errors (MEs) were recognised as a specific issue that must be assessed separately from notifications related to suspected adverse drug reactions. Thus, several policies have been developed over the years, in order to reduce MEs at the hospital. 

For each phase of the medicine-handling process – starting with purchase of products, through storage, prescription, drug dispensing from pharmacists, and finally drug administration – there are certain actions and safety measures that must be taken. For example, the qualification of suppliers is checked at the purchasing phase; ‘high alert’ drugs such as adrenaline and anesthetics are marked with a red label in the storage phase, and medicines are also sorted in a colour scheme by expiration date; the prescription phase calls for the use of standard prescriptions made according to medical protocols; and so on.

One action in particular should be highlighted: the prescription system for antimicrobial prophylaxis in surgery. There is a prescription protocol, but the physicians’ rate of compliance with it was low – less than 50% – until 2011. The problem was that they were asked to prescribe using the drug name, but as doctors usually work in two or more hospitals and each institution has its own protocol, inconsistencies occurred. At HES, a system was created where the physicians should prescribe the name of the medical procedure instead, for example cholecystectomy, which resulted in 100% compliance with the protocol.

Colour coded medicines in the hospital pharmacy. Photo: Maurício Perroud
“HES staff are studying whether the methodology used to conduct signal detection in pharmacovigilance could be used for ‘signal detection’ to prevent medication errors in hospitals.”

Two years ago, staff at HES discussed the introduction of a method to identify a risk and take early action to prevent MEs. This question is relevant because the assessment of the database is usually done by analysing the most frequent events. Focusing on this point, a pilot study was conducted, which became a research project.

In this project – which is still ongoing – HES staff are studying whether the methodology used to conduct signal detection in pharmacovigilance – namely the proportional reporting ratio methodology – could be used for ‘signal detection’ to prevent MEs in hospitals. To apply this methodology, all adverse events of one sector, e.g. the internal medicine ward, are compared with all adverse events of the other sectors. The pilot study was undertaken in 2015 on data collected between 2013–2014 and it was possible to identify a ‘signal’ for MEs. Now this methodology is promoted at HES using a database with more than 5,400 adverse events, excluding suspected adverse drug reactions, reported since January 2008. If the validity of this process can be proved, HES will start a prospective study.

Maurício Perroud
Professor of Pneumology, School of Medical Sciences, Unicamp Medical Director, Hospital Estadual Sumaré, Unicamp

You may also like


ISoP Africa gets a fresh start with its first chapter meeting in Uganda

The meeting brought together nearly 300 experts to discuss advancing pharmacovigilance practice and local data-driven decision-making on the continent.

Around the world / 16 September 2024

Celebrating 40 years of making medicines safer in Spain

This year, the Spanish pharmacovigilance system turns 40. This time has seen much success, with plans on sustaining that success in the coming four decades.

Around the world / 21 May 2024

Egypt uses active community engagement to raise awareness of herbals in healthcare

To raise awareness of phytovigilance in healthcare, ISoP Egypt created an outreach proposal centred on sharing information, experiences, and anecdotes of the safety of herbals.

Around the world / 26 June 2024